TRV GP V, LLC
- SEC CIK
- 0001990717
- Latest filing
- Aug 7, 2026
RAPP holding history
Rapport Therapeutics, Inc. in every 13F filed by TRV GP V, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RAPP overviewAll 13F holders of RAPPFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,280,525
- Value
- $261.7M
- % of portfolio
- 52.5%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,280,525 | $261.7M | 52.5% | −854,708−12.0% | Reduced | Holders |
| Q1 2026 | 7,135,233 | $223.3M | 55.7% | 00.0% | Unchanged | Holders |
| Q4 2025 | 7,135,233 | $216.5M | 50.4% | 00.0% | Unchanged | Holders |
| Q3 2025 | 7,135,233 | $211.9M | 60.0% | 00.0% | Unchanged | Holders |
| Q2 2025 | 7,135,233 | $81.1M | 49.0% | 00.0% | Unchanged | Holders |
| Q1 2025 | 7,135,233 | $71.6M | 57.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 7,135,233 | $126.6M | 43.1% | – | No prior filing | Holders |